Pages
- 1
- 2
- Evidence for the occurrence of a fast-acting inhibitor for tissue-type plasminogen activator in human plasma
- Evaluation of the specificity of antigen assays for plasminogen activator inhibitor 1: Comparison of two new commercial kits
- New aspects of blood collection and handling procedures for the assessment of t-PA and PAI-1 variables after the introduction of acid blood collection
- Constitutive synthesis of tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor type 1 (PAI-1): Conditions and therapeutic targets
- An amino acid polymorphism in histidine-rich glycoprotein (HRG) explains 59% of the variance in plasma HRG levels
- Gender-related association between β-fibrinogen genotype and plasma fibrinogen levels and linkage disequilibrium at the fibrinogen locus in Greenland Inuit
- Early spontaneous intermittent myocardial reperfusion during acute myocardial infarction is associated with augmented thrombogenic activity and less myocardial damage
- Modulation of plasma fibrinogen levels by ticlopidine in healthy volunteers and patients with stable angina pectoris
- Reduced Response to Activated Protein C Is Associated with Increased Risk for Cerebrovascular Disease
- The use of Stabilyte® plasma may cause changes in pH in the assay of some fibrinolysis analytes and might effect results
- The radial immunodiffusion assay for plasma Histidine-rich Glycoprotein (HRG) based on a polyclonal antibody, shows a different specificity towards the two variants of a common amino acid polymorphism
Pages
- 1
- 2